HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Toshio Murase Selected Research

Glycogen Storage Disease Type III (Cori's Disease)

9/2013Liver cirrhosis treated by living donor liver transplantation in a patient with AGL mutation c.2607-2610delATTC and c.1672dupA.
11/2009Molecular features of 23 patients with glycogen storage disease type III in Turkey: a novel mutation p.R1147G associated with isolated glucosidase deficiency, along with 9 AGL mutations.
1/2009Egyptian glycogen storage disease type III - identification of six novel AGL mutations, including a large 1.5 kb deletion and a missense mutation p.L620P with subtype IIId.
1/2006Molecular analysis of the AGL gene: heterogeneity of mutations in patients with glycogen storage disease type III from Germany, Canada, Afghanistan, Iran, and Turkey.
1/2002Mutational and haplotype analysis of AGL in patients with glycogen storage disease type III.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Toshio Murase Research Topics

Disease

5Glycogen Storage Disease Type III (Cori's Disease)
09/2013 - 01/2002
4Hypertriglyceridemia
11/2017 - 11/2007
3Cognitive Dysfunction
03/2015 - 04/2012
3Hyperlipoproteinemia Type III (Broad Beta Disease)
12/2012 - 03/2002
3Fatty Liver
07/2011 - 05/2010
3Type 1 Diabetes Mellitus (Autoimmune Diabetes)
10/2003 - 02/2002
2Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial)
11/2017 - 01/2015
2Alzheimer Disease (Alzheimer's Disease)
03/2015 - 03/2013
2Glycogen Storage Disease IIIA
09/2013 - 01/2005
2Hypertension (High Blood Pressure)
07/2011 - 06/2010
2Hyperuricemia
06/2010 - 05/2010
2Metabolic Syndrome (Dysmetabolic Syndrome X)
06/2010 - 05/2010
2Hyperglycemia
06/2010 - 12/2002
2Pancreatitis
03/2009 - 11/2007
2Coronary Disease (Coronary Heart Disease)
06/2008 - 09/2007
1Thyroiditis
11/2018
1Hyperthyroidism
11/2018
1Inborn Genetic Diseases (Disease, Hereditary)
11/2017
1Liver Cirrhosis (Hepatic Cirrhosis)
09/2013
1Cardiovascular Diseases (Cardiovascular Disease)
12/2012
1Dementia (Dementias)
04/2012
1Overweight
07/2011
1Obesity
06/2010
1Abdominal Obesity
05/2010
1Type 2 Diabetes Mellitus (MODY)
06/2008
1Atherosclerosis
11/2007
1Xanthomatosis (Xanthoma)
11/2007
1Hepatomegaly
10/2007
1Hypoglycemia (Reactive Hypoglycemia)
10/2007
1Cardiomyopathies (Cardiomyopathy)
10/2007
1Glycogen Storage Disease (Glycogenosis)
01/2005
1Diabetic Ketoacidosis (Ketoacidosis, Diabetic)
12/2002
1Diabetes Mellitus
04/2002
1Autoimmune Pancreatitis
04/2002
1Nephrosclerosis
03/2002
1Nephrotic Syndrome (Syndrome, Nephrotic)
03/2002
1Lipoprotein Glomerulopathy
03/2002
1Proteinuria
03/2002
1Hyperlipoproteinemias
02/2002

Drug/Important Bio-Agent (IBA)

5Glycogen Debranching Enzyme System (Glycogen Debranching Enzyme)IBA
11/2009 - 01/2002
3Insulin (Novolin)FDA Link
03/2015 - 04/2012
3GlycogenIBA
09/2013 - 01/2005
3HDL CholesterolIBA
07/2011 - 03/2010
3ApolipoproteinsIBA
03/2010 - 02/2002
2Apolipoprotein C-II (ApoC2)IBA
11/2017 - 01/2015
2Streptozocin (Streptozotocin)FDA Link
03/2015 - 03/2013
2Lipoproteins (Lipoprotein)IBA
12/2012 - 03/2002
2Lipase (Acid Lipase)FDA Link
12/2012 - 03/2009
2LDL CholesterolIBA
06/2010 - 05/2010
2gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
06/2010 - 05/2010
2TransferasesIBA
11/2009 - 01/2009
2EnzymesIBA
11/2009 - 01/2009
2Lipoprotein(a)IBA
06/2008 - 09/2007
2Lipoprotein Lipase (Diacylglycerol Lipase)IBA
11/2007 - 11/2007
2AutoantibodiesIBA
10/2003 - 12/2002
1LipidsIBA
11/2018
1Estrogens (Estrogen)FDA Link
11/2017
1Carrier Proteins (Binding Protein)IBA
03/2013
1Amyloid beta-PeptidesIBA
03/2013
1Cyclic AMP (AMP, Cyclic)IBA
03/2013
1Insulysin (Insulin-Degrading Enzyme)IBA
03/2013
1ElementsIBA
03/2013
1Cholinergic Agents (Cholinergics)IBA
04/2012
1Glucose (Dextrose)FDA LinkGeneric
04/2012
1Amyloid (Amyloid Fibrils)IBA
04/2012
1VLDL LipoproteinsIBA
03/2010
1GlucosidasesIBA
11/2009
1Proteins (Proteins, Gene)FDA Link
01/2009
1Nonsense Codon (Nonsense Mutation)IBA
10/2007
1EpitopesIBA
10/2003
1Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA
10/2003
1HLA-DQA1 antigen (HLA DQA1)IBA
12/2002
1HLA-DQ Antigens (HLA-DQ)IBA
12/2002
1Adrenal Cortex Hormones (Corticosteroids)IBA
04/2002
1Apolipoproteins E (ApoE)IBA
03/2002
1Apolipoprotein E2IBA
03/2002

Therapy/Procedure

1Therapeutics
11/2017
1Injections
03/2015
1Liver Transplantation
09/2013